Connect your AI

Elevance Health ELV Stock-Based Comp

Stock-Based Comp at other companies

HumanaHUM

$51M+4.1%

CVS HealthCVS

$266M+111%

UnitedHealth GroupUNH

$348M-7.2%

CenteneCNC

$67M+13.6%

Molina HealthcareMOH

$33M+22.2%

Oscar HealthOSCR

$15.97M-36.1%

Other financials

Income statement

Revenue$50.2B+2.6%

Gross profit$44.7B+1.8%

Net income$1.8B-19.2%

EPS (diluted)$8.00-16.8%

Balance sheet

Cash & equivalents$9.7B+28.8%

Total debt$31.5B+11.0%

Total equity$43.9B+3.3%

Total assets$125.83B+5.1%

Cash flow

Operating cash flow$4.3B+326%

CapEx$235.0M+19.9%

Free cash flow$4.1B+399%

Valuation

Market cap$83.98B+7.6%

Enterprise value$105.82B+8.0%

P/E16×+1.5×

P/S0.4×0.0×

Profitability

Gross margin89.2%+0.6pp

Net margin2.6%-0.6pp

FCF margin3.3%+1.3pp

Returns & leverage

Return on equity12.1%-2.1pp

Debt / equity0.7×+0.1×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Elevance Health in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Elevance Health’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elevance Health's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Elevance Health's stock-based comp?: Elevance Health (ELV) reported stock-based comp of $55M in Q1 2026.
How has Elevance Health's stock-based comp changed year-over-year?: Elevance Health's stock-based comp decreased by 32.1% year-over-year, from $81M to $55M.
What is the long-term trend for Elevance Health's stock-based comp?: Over 3 years (2021 to 2025), Elevance Health's stock-based comp has grown at a 2.7% compound annual growth rate (CAGR), from $255M to $276M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.